Rona R. Ramsay

University of St Andrews — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

52h-index9.5kcitations194works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Metabolism and Genetic Disorders(50), Parkinson's Disease Mechanisms and Treatments(41), Mitochondrial Function and Pathology(33), Electrochemical sensors and biosensors(25), Neuroscience and Neuropharmacology Research(20)

Publications194 total

MAO Visible Spectroscopy for Ligand Interactions, Redox Chemistry, and Kinetics of Irreversible Inhibition
Methods in molecular biology·2022
Questions in the Chemical Enzymology of MAO
Chemistry·2021· 9 citedOpen Access
Parameters for Irreversible Inactivation of Monoamine Oxidase
Molecules·2020· 21 citedOpen Access
Enzymes | Monoamine Oxidase (EC 1.4.3.4)
Elsevier eBooks·2020
Design, synthesis, molecular modelling and<i>in vitro</i>screening of monoamine oxidase inhibitory activities of novel quinazolyl hydrazine derivatives
Royal Society Open Science·2020· 7 citedOpen Access
Neuroprotective actions of leptin facilitated through balancing mitochondrial morphology and improving mitochondrial function
Journal of Neurochemistry·2020· 18 citedOpen Access
Supplementary material from "Design, synthesis, molecular modelling and <i>in vitro</i> screening of monoamine oxidase inhibitory activities of novel quinazolyl hydrazine derivatives"
Figshare·2020Open Access
Synthesis, biological evaluation, and molecular modeling of nitrile‐containing compounds: Exploring multiple activities as anti‐Alzheimer agents
Drug Development Research·2019· 10 cited
Molecular Aspects of the Activity and Inhibition of the FAD-Containing Monoamine Oxidases
2019· 1 citedOpen Access
Electron carriers and energy conservation in mitochondrial respiration
ChemTexts·2019· 58 citedOpen Access
Evidence for a Cyanine Link Between Propargylamine Drugs and Monoamine Oxidase Clarifies the Inactivation Mechanism
Frontiers in Chemistry·2018· 30 citedOpen Access
Kinetics, mechanism, and inhibition of monoamine oxidase
Journal of Neural Transmission·2018· 104 cited
A perspective on multi‐target drug discovery and design for complex diseases
Clinical and Translational Medicine·2018· 685 citedOpen Access
Multitarget‐Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H<sub>3</sub>R Antagonism for Neurodegenerative Diseases
Angewandte Chemie International Edition·2017· 100 cited
Multipotente Liganden mit kombinierter Cholinesterase‐ und Monoaminooxidase‐Inhibition sowie Histamin‐H<sub>3</sub>R‐Antagonismus bei neurodegenerativen Erkrankungen
Angewandte Chemie·2017· 3 cited
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs
Molecules·2017· 232 citedOpen Access
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs&lt;strong&gt; &lt;/strong&gt;
Preprints.org·2017· 36 citedOpen Access
Neurobiology and neuropharmacology of monoaminergic systems
Progress in Neurobiology·2017· 13 citedOpen Access
Editorial: Structure-Based Drug Design for Diagnosis and Treatment of Neurological Diseases
Frontiers in Pharmacology·2017· 5 citedOpen Access
Ciproxifan, a histamine H3 receptor antagonist, reversibly inhibits monoamine oxidase A and B
Scientific Reports·2017· 34 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Thomas P. Singer(16), José Marco‐Contelles(5), Katarina Nikolić(3), James I. Salach(3), M. Krueger(3), Stephen K. Youngster(3), Arduino Arduini(3), Mercedes Unzeta(3), Gerard Esteban(3), Kathleen A. McKeown(3), Jahan Dadgar(2), Neal Castagnoli(2), Anthony J. Trevor(2), Keith F. Tipton(2), Martin R. Gluck(2), John E. Casida(2), Philip K. Tubbs(2), Irene Bolea(2), Óscar M. Bautista‐Aguilera(2), Lhassane Ismaïli(2)